Perceval S主动脉生物瓣植入后血小板减少
回顾性比较Perceval S与其他主动脉生物瓣术后血小板计数,发现Perceval S组术后最低血小板计数显著更低,但未发现出血、输血或再手术率的显著差异。
要点
- Perceval S术后血小板计数下降更明显
- 血小板减少未导致临床不良后果
- 需进一步研究确认并探究原因
核心结论
- Perceval S术后血小板计数下降较其他生物瓣更严重,但小样本研究未发现不良临床影响。
研究设计与样本
- 回顾性研究纳入87例主动脉瓣置换患者,Perceval S组25例,Labcor组23例,Hancock II组39例。
主要发现
- 血小板计数差异持续至出院或死亡。
- 出血、输血需求或再手术率无显著差异。
临床怎么用
- 使用Perceval S时应关注血小板计数下降,但无需过度担心临床出血事件。
局限性
- 样本量小,需未来研究确认并探究原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Perceval S bioprosthesis (LivaNova PLC, London, United Kingdom) is based on the Freedom Solo aortic bioprosthesis (LivaNova PLC), which has been reported to be associated with perioperative thrombocytopenia. We compared platelet counts after aortic valve replacement with the Perceval S with those with other aortic valve bioprostheses. METHODS: A total of 87 patients receiving aortic valve replacement were included in this retrospective study; 25 patients received the Perceval S, 23 patients received the Labcor TLPB-A (Labcor, Belo Horizonte, Brazil), and 39 patients received the Hancock II bioprosthesis (Medtronic, Minneapolis, Minn). Thrombocyte count was corrected for hematocrit. Multivariable analyses were performed to assess the potential effect of other variables. RESULTS: Preoperatively, there were no differences in platelet counts comparing the Perceval S group (median 200/nl, interquartile range, 157-252) and the control group (Labcor: median 213/nl, interquartile range, 160-246, Hancock: median 227/nl, interquartile range, 183-280, P = .23). Postoperatively, there was significant evidence that the minimum platelet count (median, Perceval: 47, interquartile range, 38-66; Labcor: 76, interquartile range, 61-110; Hancock: 78, interquartile range, 61-111/nl; P = .001), both absolute and corrected, was lower for the Perceval S, even after allowing for other variables. The significant difference in absolute platelet counts persisted until discharge or death. However, there were no significant differences regarding blood loss, transfusion requirements, or rates of reoperation for bleeding. CONCLUSIONS: After aortic valve replacement, platelet counts in patients with the Perceval S decrease more severely compared with other bioprostheses, but in our small study we found no evidence of a detrimental clinical effect of this phenomenon. Future studies have to confirm our findings and investigate a cause for this phenomenon.
引用
- Stegmeier P, Schlömicher M, Stiegler H, et al. Thrombocytopenia after implantation of the Perceval S aortic bioprosthesis. J Thorac Cardiovasc Surg. 2019. PMID: 31668534. doi:10.1016/j.jtcvs.2019.07.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。